中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
MeSH:(Triptorelin Pamoate/*administration )

1.Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty.

Yan LIANG ; Hong WEI ; Jian-ling ZHANG ; Ling HOU ; Xiao-ping LUO

Chinese Journal of Pediatrics 2004;42(11):845-849

2.Ovarian Hyper-Response to Administration of an GnRH-Agonist Without Gonadotropins.

Hyun Tae PARK ; Hyo Sook BAE ; Tak KIM ; Sun Haeng KIM

Journal of Korean Medical Science 2011;26(10):1394-1396

3.Efficacy and safety of long-acting gonadotropin-releasing hormone analogue in the treatment for metastatic prostate cancer.

Ning-chen LI ; Yi SONG ; Hao-wen JIANG ; Qiang DING ; Wei-dong GAN ; Hong-qian GUO ; Ze-yu SUN ; Zhi-quan HU ; Zhang-qun YE ; Qiang WEI ; Yan-qun NA

Chinese Journal of Surgery 2008;46(21):1653-1657

4.Effect of low-dose triptorelin on pituitary down-regulation for patients undergoing in vitro fertilization and embryo transfer.

Wen-Jie ZHU ; Xue-Mei LI ; Xiu-Ming CHEN ; Li ZHANG

National Journal of Andrology 2003;9(5):367-369

5.Does lower dose of long-acting triptorelin maintain pituitary suppression and produce good live birth rate in long down-regulation protocol for in-vitro fertilization?

Xin CHEN ; Shu-xian FENG ; Ping-ping GUO ; Yu-xia HE ; Yu-dong LIU ; De-sheng YE ; Shi-ling CHEN

Journal of Huazhong University of Science and Technology (Medical Sciences) 2016;36(2):215-220

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO